17. Trento: 16 – 18 June 2005
MOLECULAR UNDERSTANDING OF SOLID TUMORS
16. Trento, 10 – 12 June 2004
STEM CELLS AND EPIGENESIS IN CANCER
15. Rovereto, 12 – 14 June 2003
MOLECULAR IN VIVO VISUALISATION OF CANCER CELLS
14. Trento, 30 May – 1 June 2002
THE NOVEL DICHOTOMY OF IMMUNE INTERACTIONS WITH TUMORS
13. Rovereto, 31 May – 2 June 2001
FOCUSING ANALYTICAL TOOLS ON COMPLEXITY IN CANCER
12. Trento, 1 -3 June 2000
SIGNALING CROSS-TALKS IN CANCER CELLS
11. Rovereto, 5- 7 June 1999
MOLECULAR HORIZONS IN CANCER THERAPEUTICS
10. Trento, 29 June - 1 July 1998
THE GENETICS OF CANCER SUSCEPTIBILITY
9. Rovereto, 4 – 7 June 1997
THE BIOLOGY OF TUMORS
8. Trento, 17 – 19 June 1996
GENOMIC INSTABILITY AND IMMORTALITY IN CANCER
7. Trento, 14 – 16 June 1995
CANCER GENES. FUNCTIONAL ASPECTS
6. Rovereto, 29 June – 1 July 1994
NORMAL AND MALIGNANT HEMATOPOIESIS: NEW ADVANCES
5. Trento, 9 – 11 June 1993
APOPTOSIS
4. Rovereto, 24 – 26 June 1992
ADHESION MOLECULES: CELLULAR RECOGNITION MECHANISMS
3. Trento, 5 – 7 June 1991
TUMOR SUPPRESSOR GENES
2. Rovereto, 11 – 13 June 1990
THE THERAPEUTIC IMPLICATIONS OF THE MOLECULAR BIOLOGY OF BREAST CANCER
1. Trento, 19 – 21 June 1989
DRUG RESISTANCE: MECHANISMS AND REVERSAL
